NJ

Noopur Jha

Active Director Director DIN 10620221
DIN 10620221 First appointment Jun 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2024
Shareholding value Locked Premium profile

About Noopur Jha

Noopur Jha has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Biodeal Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10620221
Primary Designation Director
First Appointment 14 Jun 2024
Oldest Company Age 20 yrs

Current companies

Company Designation Appointment Founded Status
Biodeal Pharmaceuticals Limited U00304HP2005PLC029451
Director 14 Jun 2024 2005 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biodeal Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Noopur Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Noopur Jha

Noopur Jha has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Biodeal Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Noopur Jha is associated with 1 company as Director.

Noopur Jha has expertise in General Business.

Noopur Jha has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available